Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06942949 · ClinicalTrials.gov registry record · NA
Evaluation of Enhanced Lithotripsy System (ELS) in the Treatment of Urinary Stones, A Pivotal Trial
A NA study of Kidney Calculi; Ureteral Calculi, sponsored by Avvio Medical.
- Recruiting
- Registry status
- NA
- Development phase
- 101
- Enrollment target
- 16
- Study locations
NCT06942949 is a NA study of Kidney Calculi; Ureteral Calculi that is actively recruiting participants, run by Avvio Medical. The registered enrollment target is 101 participants. The trial reports 16 study locations across 11 states.
The verdict
NCT06942949, a NA study of Kidney Calculi; Ureteral Calculi, is actively recruiting participants, sponsored by Avvio Medical.
- RECRUITING
- Registry status
- NA
- Development phase
- 101 participants
- Enrollment target
- 16
- Study locations
Study Summary
The purpose of this study is to evaluate the safety and performance of the ELS to treat urinary stones. The ELS is intended to break urinary stones into small fragments that can pass during or after the procedure with less or no discomfort. Eligible patients are male or females, age 21 or older, with a single urinary stone in the ureter. Participants will undergo the ELS procedure and then be evaluated 30 days later for the presence or absence of urinary stone fragments on a CT scan. Subjects who still have stone present at Day 30 will be evaluated again at Day 60. Other outcome measures will be changes in pain, quality of life, and return to normal daily activities/work.
Conditions Studied
Interventions
- DEVICE ELS (Enhanced Lithotripsy System)
Study Locations (16)
California
- Michael G. Oefelein Clinical Trials - Bakersfield
- San Diego Clinical Trials - La Mesa
- Golden State Urology - Sacramento
Virginia
- University of Virginia - Charlottesville
- University of Virginia Community Health - Culpeper
- Urology of Virginia - Virginia Beach
New York
- University of Rochester Medical Center - Rochester
- SUNY - Upstate Medical University - Syracuse
Arizona
- Arizona State Urological Research Institute - Phoenix
Florida
- University of Miami Hospital - Miami
Georgia
- Georgia Urology - Roswell
Illinois
- Comprehensive Urologic Care - Lake Barrington
Kansas
- Wichita Urology Group - Wichita
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 101 participants |
| Start Date | 2025-05-01 |
| Est. Completion | 2026-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06942949
The ClinicalTrials.gov registry entry for NCT06942949 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 101 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Avvio Medical, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Kidney Calculi; Ureteral Calculi appearing as the primary indexed condition, and to 1 intervention - of which ELS (Enhanced Lithotripsy System) is the first listed.
NCT06942949 reports 16 study locations spanning 11 distinct geographic areas - top geographies include California, Virginia, New York.
Frequently Asked Questions
What is clinical trial NCT06942949 about?
NCT06942949 is a clinical study titled "Evaluation of Enhanced Lithotripsy System (ELS) in the Treatment of Urinary Stones, A Pivotal Trial". The purpose of this study is to evaluate the safety and performance of the ELS to treat urinary stones. The ELS is intended to break urinary stones into small fragments that can pass during or after the procedure with less or no discomfort. Eligible patients are male or females, age 21 or older, wit...
What is the current status of trial NCT06942949?
This trial is currently recruiting. It is a NA study. The enrollment target is 101 participants. The study started on 2025-05-01. Estimated completion is 2026-07.
What conditions does trial NCT06942949 study?
This clinical trial studies the following conditions: Kidney Calculi; Ureteral Calculi.
What interventions are being tested in trial NCT06942949?
The interventions under investigation include: ELS (Enhanced Lithotripsy System) (DEVICE).
Who is sponsoring clinical trial NCT06942949?
This trial is sponsored by Avvio Medical, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06942949 being conducted?
This trial has 16 study locations across Arizona, California, Florida, Georgia, Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.